A Case of Diffuse Alveolar Hemorrhage Following Abciximab Therapy
Open Access
- 1 January 2013
- journal article
- Published by Korean Association of Internal Medicine in Korean Journal of Medicine
- Vol. 84 (4), 562-566
- https://doi.org/10.3904/kjm.2013.84.4.562
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approachEuropean Heart Journal, 2007
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitorInternational Journal of Cardiology, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationThe New England Journal of Medicine, 1997
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE studyThe Lancet, 1997
- Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary InterventionCirculation, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994